← Scroll for more →
Opus Genetics, Inc. (IRD)
Pharmaceutical Preparations
Latest Price
$3.67
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.22
P/B Ratio
16.49
Institutional Ownership
69.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Caligan Partners LP | 6.08M | $24.0M | 7.35% | +2.1K | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 6.03M | $24.0M | 7.30% | -- | 2026-06-30 |
| BIOS Capital Management, LP | 3.68M | $15.0M | 4.46% | -- | 2026-06-30 |
| BlackRock, Inc. | 3.12M | $12.0M | 3.77% | +2.97M | 2026-06-30 |
| Balyasny Asset Management L.P. | 3.09M | $12.0M | 3.74% | +369.8K | 2026-06-30 |
| Nantahala Capital Management, LLC | 3.06M | $12.0M | 3.70% | +1.38M | 2026-06-30 |
| Vanguard Capital Management LLC | 2.96M | $12.0M | 3.58% | +508.7K | 2026-06-30 |
| Boxer Capital Management, LLC | 2.81M | $11.0M | 3.41% | +565.0K | 2026-06-30 |
| Trails Edge Capital Partners, LP | 2.74M | $11.0M | 3.32% | +2.24M | 2026-06-30 |
| Millennium Management LLC | 2.30M | $9.0M | 2.79% | -328.3K | 2026-06-30 |